RGPD8
geneOn this page
Also known as RanBP2alpha
Summary
RGPD8 (RANBP2 like and GRIP domain containing 8, HGNC:9849) is a protein-coding gene on chromosome 2q14.1, encoding RANBP2-like and GRIP domain-containing protein 8 (O14715).
Predicted to enable small GTPase binding activity. Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm.
Source: NCBI Gene 727851 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 200 total — 2 pathogenic
- MANE Select transcript:
NM_001164463
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9849 |
| Approved symbol | RGPD8 |
| Name | RANBP2 like and GRIP domain containing 8 |
| Location | 2q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RanBP2alpha |
| Ensembl gene | ENSG00000169629 |
| Ensembl biotype | protein_coding |
| OMIM | 602752 |
| Entrez | 727851 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000302558, ENST00000330575, ENST00000409750, ENST00000471422, ENST00000482903, ENST00000496537, ENST00000522286, ENST00000929966
RefSeq mRNA: 1 — MANE Select: NM_001164463
NM_001164463
CCDS: CCDS46394
Canonical transcript exons
ENST00000302558 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002439741 | 112421960 | 112422112 |
| ENSE00002447820 | 112417193 | 112417338 |
| ENSE00002457769 | 112378053 | 112378254 |
| ENSE00002459041 | 112422548 | 112422659 |
| ENSE00002461552 | 112380824 | 112380963 |
| ENSE00002467742 | 112433382 | 112433645 |
| ENSE00002480479 | 112401117 | 112401240 |
| ENSE00002483202 | 112417684 | 112417914 |
| ENSE00002517895 | 112388024 | 112390247 |
| ENSE00002523283 | 112403966 | 112404175 |
| ENSE00003533182 | 112424240 | 112424307 |
| ENSE00003564739 | 112400036 | 112400194 |
| ENSE00003586760 | 112406297 | 112406384 |
| ENSE00003604039 | 112394618 | 112394753 |
| ENSE00003610246 | 112390975 | 112391069 |
| ENSE00003624035 | 112401667 | 112401848 |
| ENSE00003642132 | 112399632 | 112399769 |
| ENSE00003653293 | 112397922 | 112398005 |
| ENSE00003664074 | 112412431 | 112412626 |
| ENSE00003674443 | 112398099 | 112398278 |
| ENSE00003689127 | 112401408 | 112401583 |
| ENSE00003692916 | 112399223 | 112399369 |
| ENSE00003894210 | 112368369 | 112370212 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 89.83.
FANTOM5 (CAGE): breadth broad, TPM avg 1.1300 / max 26.2194, expressed in 570 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 202335 | 1.1300 | 570 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.83 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.49 | gold quality |
| sural nerve | UBERON:0015488 | 83.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.66 | gold quality |
| right testis | UBERON:0004534 | 82.97 | gold quality |
| testis | UBERON:0000473 | 82.95 | gold quality |
| bone marrow cell | CL:0002092 | 82.02 | gold quality |
| left testis | UBERON:0004533 | 81.95 | gold quality |
| bone marrow | UBERON:0002371 | 81.55 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.47 | gold quality |
| tonsil | UBERON:0002372 | 79.13 | gold quality |
| ventricular zone | UBERON:0003053 | 78.89 | gold quality |
| primary visual cortex | UBERON:0002436 | 78.52 | gold quality |
| mucosa of stomach | UBERON:0001199 | 78.36 | gold quality |
| right coronary artery | UBERON:0001625 | 78.29 | gold quality |
| adenohypophysis | UBERON:0002196 | 77.89 | gold quality |
| pituitary gland | UBERON:0000007 | 77.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.52 | gold quality |
| body of pancreas | UBERON:0001150 | 77.12 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 77.07 | gold quality |
| endometrium | UBERON:0001295 | 77.02 | gold quality |
| pancreas | UBERON:0001264 | 77.00 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 76.99 | gold quality |
| cortical plate | UBERON:0005343 | 76.65 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 76.48 | gold quality |
| thoracic aorta | UBERON:0001515 | 76.35 | gold quality |
| ascending aorta | UBERON:0001496 | 76.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.10 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.07 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 76.07 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7606 | no | 37.80 |
| E-ANND-3 | no | 3.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
123 targeting RGPD8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ranbp3a | ENSDARG00000008727 |
| drosophila_melanogaster | RanBP3 | FBGN0039110 |
Paralogs (10): RGPD5 (ENSG00000015568), RANBP3 (ENSG00000031823), RANBP1 (ENSG00000099901), RGPD3 (ENSG00000153165), RANBP2 (ENSG00000153201), RANBP3L (ENSG00000164188), RGPD6 (ENSG00000183054), RGPD2 (ENSG00000185304), RGPD1 (ENSG00000187627), RGPD4 (ENSG00000196862)
Protein
Protein identifiers
RANBP2-like and GRIP domain-containing protein 8 — O14715 (reviewed: O14715)
Alternative names: Ran-binding protein 2-like 3
All UniProt accessions (5): C9J6W1, O14715, F8W705, H0YBN8, J3KQ37
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with GTP-bound ARL1.
Miscellaneous. One of the 8 copies of RANBP2 clustered close to the chromosome 2 centromere.
RefSeq proteins (1): NP_001157935* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000156 | Ran_bind_dom | Domain |
| IPR000237 | GRIP_dom | Domain |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR019734 | TPR_rpt | Repeat |
| IPR032023 | GCC2_Rab_bind | Domain |
| IPR045255 | RanBP1-like | Family |
Pfam: PF00638, PF01465, PF16704
UniProt features (23 total): region of interest 5, compositionally biased region 5, sequence conflict 4, repeat 3, domain 3, modified residue 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14715-F1 | 67.28 | 0.28 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 19, 21
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOMF_GTPASE_BINDING, GOBP_NUCLEAR_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS, GOBP_NUCLEAR_EXPORT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, chr2q14, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_PORE, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_SUMO_TRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY
GO Biological Process (2): NLS-bearing protein import into nucleus (GO:0006607), intracellular transport (GO:0046907)
GO Molecular Function (3): small GTPase binding (GO:0031267), GTPase activator activity (GO:0005096), protein binding (GO:0005515)
GO Cellular Component (2): nuclear pore (GO:0005643), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 2 |
| protein import into nucleus | 1 |
| transport | 1 |
| cellular localization | 1 |
| establishment of localization in cell | 1 |
| GTPase binding | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| nuclear envelope | 1 |
| nuclear protein-containing complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1624 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RGPD8 | GRIP1 | Q9Y3R0 | 855 |
| RGPD8 | GOLGA4 | Q13439 | 673 |
| RGPD8 | GOLGA1 | Q92805 | 671 |
| RGPD8 | GCC1 | Q96CN9 | 512 |
| RGPD8 | M0QZ92 | M0QZ92 | 418 |
| RGPD8 | GCC2 | Q8IWJ2 | 405 |
| RGPD8 | RNASE4 | P34096 | 398 |
| RGPD8 | SYS1 | Q8N2H4 | 315 |
| RGPD8 | RUSC1 | Q9BVN2 | 311 |
| RGPD8 | ARFIP2 | P53365 | 304 |
| RGPD8 | CCDC186 | Q7Z3E2 | 304 |
| RGPD8 | RUNDC3A | Q59EK9 | 298 |
| RGPD8 | MON2 | Q7Z3U7 | 287 |
| RGPD8 | ARFRP1 | Q13795 | 269 |
| RGPD8 | GBF1 | Q92538 | 260 |
IntAct
103 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UCHL5 | PSMD11 | psi-mi:“MI:0914”(association) | 0.840 |
| CENPS | CENPX | psi-mi:“MI:0914”(association) | 0.810 |
| EXOC3 | EXOC5 | psi-mi:“MI:0914”(association) | 0.790 |
| NUP50 | KPNA3 | psi-mi:“MI:0914”(association) | 0.780 |
| PSMD13 | PSMD11 | psi-mi:“MI:0914”(association) | 0.750 |
| PSMC5 | PSMD11 | psi-mi:“MI:0914”(association) | 0.730 |
| PSMD2 | PSMD11 | psi-mi:“MI:0914”(association) | 0.730 |
| FAM136A | RBFOX3 | psi-mi:“MI:0914”(association) | 0.640 |
| NEMP1 | RGPD8 | psi-mi:“MI:0914”(association) | 0.640 |
| RAN | RGPD8 | psi-mi:“MI:0914”(association) | 0.640 |
| B2M | NEMP1 | psi-mi:“MI:0914”(association) | 0.640 |
| MIA2 | RGPD8 | psi-mi:“MI:0914”(association) | 0.640 |
| KPNB1 | POM121C | psi-mi:“MI:0914”(association) | 0.530 |
| RAN | NEMP2 | psi-mi:“MI:0914”(association) | 0.530 |
| MIA2 | RGPD3 | psi-mi:“MI:0914”(association) | 0.530 |
| AKIRIN2 | RGPD3 | psi-mi:“MI:0914”(association) | 0.530 |
| LGALS3BP | RGPD8 | psi-mi:“MI:0914”(association) | 0.530 |
| IER2 | KPNA3 | psi-mi:“MI:0914”(association) | 0.530 |
| MLLT6 | RGPD8 | psi-mi:“MI:0914”(association) | 0.530 |
| TSKS | RGPD8 | psi-mi:“MI:0914”(association) | 0.530 |
| DISC1 | AP4M1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (105): RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4K7J2, A1ZAK1, A6NKT7, F4J8D3, G5ED39, H2QII6, O01510, O14715, O48767, P0DJD0, P0DJD1, P12798, P33144, P40358, P42286, P49792, Q00416, Q0IEK6, Q18508, Q18892, Q20937, Q291E4, Q2U639, Q4WVM7, Q5B8K7, Q61CW2, Q61WP7, Q6C9G0, Q6CXL5, Q6FUS3, Q6FVG5, Q70PP2, Q751J3, Q754V0, Q759B7, Q759Y1, Q75B70, Q75CM2, Q7TSH2, Q7Z3J3
Diamond homologs: A0A0B4K7J2, A6NKT7, E9Q3G8, H2QII6, O14715, P0DJD0, P0DJD1, P34022, P40517, P41920, P43487, P92985, Q09717, Q3T0M7, Q54KD9, Q7Z3J3, Q8RWG8, Q99666, Q9C829, Q9LMK7, Q9USL4, D3ZZL9, P32499, P34562, P48820, P49792, Q8CHG3, Q8IWJ2, Q9ERU9, G0S8I1, Q09146, Q86VV4, A0A075B759, A0A075B767, A0A0B4J2A2, A0A0R0H9T5, A4FV72, D4AY02, F5H284, O00060
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 100 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Nuclear import of Rev protein | 10 | 63.4× | 7e-14 |
| Rev-mediated nuclear export of HIV RNA | 10 | 59.9× | 7e-14 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 9 | 58.8× | 1e-12 |
| NS1 Mediated Effects on Host Pathways | 10 | 53.9× | 2e-13 |
| Transport of Ribonucleoproteins into the Host Nucleus | 8 | 53.9× | 7e-11 |
| IPs transport between nucleus and cytosol | 7 | 50.3× | 2e-09 |
| IP3 and IP4 transport between cytosol and nucleus | 7 | 50.3× | 2e-09 |
| IP6 and IP7 transport between cytosol and nucleus | 7 | 50.3× | 2e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| NLS-bearing protein import into nucleus | 5 | 47.2× | 9e-06 |
| nucleocytoplasmic transport | 7 | 32.3× | 4e-07 |
| protein import into nucleus | 12 | 20.3× | 3e-10 |
| mRNA transport | 6 | 18.6× | 1e-04 |
| mRNA export from nucleus | 5 | 17.4× | 8e-04 |
| exocytosis | 6 | 10.7× | 1e-03 |
| chromosome segregation | 5 | 10.2× | 6e-03 |
| cell division | 9 | 4.9× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
200 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 178 |
| Likely benign | 16 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1807763 | GRCh37/hg19 2q13(chr2:111369264-113142794)x1 | Pathogenic |
| 2580318 | GRCh37/hg19 2q13(chr2:111335152-113127204)x1 | Pathogenic |
SpliceAI
3151 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:112370222:G:GC | acceptor_gain | 1.0000 |
| 2:112378040:T:A | donor_gain | 1.0000 |
| 2:112378049:CCA:C | donor_loss | 1.0000 |
| 2:112378050:CA:C | donor_loss | 1.0000 |
| 2:112378258:G:GC | acceptor_gain | 1.0000 |
| 2:112378261:T:C | acceptor_gain | 1.0000 |
| 2:112378261:T:TC | acceptor_gain | 1.0000 |
| 2:112380818:TCTCA:T | donor_loss | 1.0000 |
| 2:112380819:CTCA:C | donor_loss | 1.0000 |
| 2:112380820:TCA:T | donor_loss | 1.0000 |
| 2:112380821:CA:C | donor_loss | 1.0000 |
| 2:112380823:CC:C | donor_loss | 1.0000 |
| 2:112390962:ATT:A | donor_gain | 1.0000 |
| 2:112390964:T:TA | donor_gain | 1.0000 |
| 2:112391070:C:CC | acceptor_gain | 1.0000 |
| 2:112394613:CTCA:C | donor_loss | 1.0000 |
| 2:112394614:TCA:T | donor_loss | 1.0000 |
| 2:112394615:CAC:C | donor_loss | 1.0000 |
| 2:112394616:A:AT | donor_loss | 1.0000 |
| 2:112394617:C:A | donor_loss | 1.0000 |
| 2:112394750:CTTT:C | acceptor_gain | 1.0000 |
| 2:112394754:C:CC | acceptor_gain | 1.0000 |
| 2:112394757:T:TC | acceptor_gain | 1.0000 |
| 2:112397917:CTTA:C | donor_loss | 1.0000 |
| 2:112397918:TTA:T | donor_loss | 1.0000 |
| 2:112397919:TA:T | donor_loss | 1.0000 |
| 2:112397920:A:AC | donor_gain | 1.0000 |
| 2:112397920:AC:A | donor_gain | 1.0000 |
| 2:112397921:C:CA | donor_gain | 1.0000 |
| 2:112397921:CC:C | donor_gain | 1.0000 |
AlphaMissense
11594 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:112422600:C:T | G67D | 0.998 |
| 2:112422601:C:G | G67R | 0.998 |
| 2:112388663:A:G | W1428R | 0.997 |
| 2:112388663:A:T | W1428R | 0.997 |
| 2:112389554:A:G | W1131R | 0.996 |
| 2:112389554:A:T | W1131R | 0.996 |
| 2:112424246:G:T | A45D | 0.996 |
| 2:112424282:G:T | A33E | 0.996 |
| 2:112389469:A:G | F1159S | 0.995 |
| 2:112389495:A:C | F1150L | 0.995 |
| 2:112389495:A:T | F1150L | 0.995 |
| 2:112389496:A:G | F1150S | 0.995 |
| 2:112389497:A:G | F1150L | 0.995 |
| 2:112422004:C:G | A121P | 0.995 |
| 2:112422063:G:T | A101E | 0.995 |
| 2:112422064:C:G | A101P | 0.995 |
| 2:112422553:A:C | Y83D | 0.995 |
| 2:112422565:C:G | A79P | 0.995 |
| 2:112422603:A:G | L66P | 0.995 |
| 2:112389468:G:C | F1159L | 0.994 |
| 2:112389468:G:T | F1159L | 0.994 |
| 2:112389470:A:G | F1159L | 0.994 |
| 2:112422564:G:T | A79D | 0.994 |
| 2:112422594:A:G | L69P | 0.994 |
| 2:112388558:C:G | A1463P | 0.993 |
| 2:112388611:A:T | V1445D | 0.993 |
| 2:112389552:C:A | W1131C | 0.993 |
| 2:112389552:C:G | W1131C | 0.993 |
| 2:112401807:A:G | W440R | 0.993 |
| 2:112401807:A:T | W440R | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000043652 (2:112430520 C>A), RS1000097726 (2:112380412 G>A), RS1000138102 (2:112430789 C>A,T), RS1000203792 (2:112413703 T>C), RS1000382912 (2:112369895 T>C), RS1000503754 (2:112422716 C>G,T), RS1000598025 (2:112423952 G>A,C), RS1000705052 (2:112373638 C>T), RS1000717430 (2:112414777 T>C,G), RS1001116073 (2:112375057 T>C), RS1001608630 (2:112392788 A>C), RS1002337606 (2:112434418 G>A), RS1002384576 (2:112429289 C>A,T), RS1002482588 (2:112429618 C>T), RS1002734103 (2:112434261 CG>C)
Disease associations
OMIM: gene MIM:602752 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): 2q13 microdeletion syndrome (MONDO:0975887)
Orphanet (1): 2q13 microdeletion syndrome (Orphanet:684742)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Selenium | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vitamin E | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): 2q13 microdeletion syndrome